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Noninvasive evaluation of the carotid artery and its
branches has progressed from indirect assessment of the
hemodynamic consequences of carotid occlusive disease to
direct assessment with real-time B-mode imaging and
pulsed Doppler techniques. More recently, advances in
magnetic resonance and high resolution computed tomo-
graphic angiography have permitted noninvasive three-
dimensional visualization of the extracranial and intracra-
nial circulation. During the same time period, cerebral
imaging has progressed from conventional computed to-
mography and magnetic resonance imaging techniques to
the more advanced and constantly unfolding applications
of 1H magnetic resonance spectroscopy (MRS), 31P MRS,
and functional magnetic resonance imaging.
1H MRS has made it possible to investigate cerebral
metabolism in vivo and noninvasively. It can provide sig-
nificant insight into the neurochemical alterations associ-
ated with ischemic, infectious, and neoplastic pathology by
measuring markers of neuronal density, regeneration, and
maturation; indices of phospholipid metabolism and glio-
sis; and indirect markers of energy reserve and storage. The
molecules primarily visible with 1H MRS are: N-acetylas-
partate, choline, creatine, and myo-inostitol.1
N-acetylaspartate is widely used as a marker of neuronal
density.1 It has been shown that N-acetylaspartate is syn-
thesized exclusively in the mitochondria of neurons, and
decreases in N-acetylaspartate may be due, at least in part,
to reduction in mitochondrial metabolism.2 Thus, revers-
ible N-acetylaspartate losses may be associated with recov-
ery of mitochondrial metabolism. Neuronal cell death will
cause an irreversible loss of N-acetylaspartate due to the
localization of N-acetylaspartate in the neuron.
The choline peak mainly consists of glycerophospho-
choline and phosphocholine compounds. These molecules
are involved in cellular biosynthesis of phospholipids and
the synthesis of acetylcholine in neurons.
Total creatine concentration is the amount of creatine
plus phosphocreatine in brain tissue. Creatine is part of the
creatine kinase energy metabolism buffer system used to
maintain adenosine triphoshate (ATP) levels in times of
acute mismatch between oxidative ATP supply and ATP
demand. Total creatine tends to remain relatively constant
in most brain cell types, and when comparing similar cell
populations, it can be used as a concentration reference for
the other measured molecules.
Myo-inostitol appears to act as a marker of glial cell
numbers,3 an osmoregulator, and an intracellular messen-
ger.3
In animal models, a rapid decline in N-acetylaspartate
was shown within the first 8 hours after the onset of focal
ischemia.4 This was followed with a slower rate of reduction
over the next 24 hours. Most studies have been able to
correlate an increase in cerebral lactate with a decrease in
N-acetylaspartate.
In an animal model5 of global ischemia, followed by
recirculation, choline levels progressively decreased during
reperfusion and were lower than those in control animals
after 150 minutes of recirculation. The increased choline
levels after ischemia may be associated with cellular and
phospholipid breakdown or the degradation of acetylcho-
line. Although experimental models have shown an in-
crease in choline, clinical models have either shown no
change or a reduction.
Initial publications using in vivo 1H MRS to evaluate
human cerebral ischemia began to appear around 1990.
Studies to date have assessed either the metabolic changes
associated with an ischemic event (stroke or transient isch-
emic attack) or those associated with a carotid stenosis or
occlusion. Studies evaluating metabolic changes after an
ischemic event have been further divided into those per-
formed acutely after stroke and those evaluating changes
occurring from 2 to 6 months after an ischemic event.
Measured metabolites include N-acetylaspartate, choline,
creatine, and lactate. N-acetylaspartate and choline have
been reported as absolute values and relative to creatine;
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and N-acetylaspartate has also been reported relative to
choline (N-acetylaspartate/choline). Most studies evaluat-
ing patients after an ischemic event have shown a decrease
in N-acetylaspartate or the N-acetylaspartate/creatine ra-
tio. Several studies have shown insignificant reductions in
N-acetylaspartate/creatine and the choline/creatine ratios
but significant reductions in the N-acetylaspartate/choline
ratio. These would imply either a reduction in N-acetylas-
partate, an increase in choline, or a relative reduction in
N-acetylaspartate compared with choline. Those studies
evaluating asymptomatic ischemia caused by carotid steno-
sis or occlusion have either shown a reduction in N-ace-
tylaspartate or no change.
In this issue of the Journal of Vascular Surgery, Kim and
associates evaluated changes in cerebral metabolism after
carotid endarterectomy in 18 patients with asymptomatic
internal carotid artery stenoses exceeding 70% in diameter.
These patients were compared with 16 control subjects.
The patients with asymptomatic carotid artery stenoses had
no evidence of infarction with magnetic resonance imag-
ing. They were evaluated with carotid duplex ultrasonog-
raphy, 1H MRS, and either magnetic resonance or contrast
cerebral arteriography before surgery. Seven days after sur-
gery, they were evaluated with 1H MRS. Carotid duplex
ultrasonography and volume flow measurements were ob-
tained 2 to 3 weeks after surgery.
The authors measured N-acetylaspartate, choline, and
myo-inostitol. Creatine was assessed and assumed to be a
stable metabolite and was used as an index. The authors
concluded that the N-acetylaspartate/creatine and cho-
line/creatine ratios in the hemisphere ipsilateral to carotid
endarterectomy significantly increased in comparison with
preoperative values. However, the values before and after
endarterectomy were not significantly different from those
in the control population. 1H MRS was also used to assess
the contralateral hemisphere. The authors noted no change
in the N-acetylaspartate/creatine ratio but did note an
increase in the choline/creatine ratio and a decrease in the
myo-inostitol/creatine ratios.
In analysis of the results of this study, the following
limitations should be considered. Use of creatine as an
index may generate considerable errors caused by varia-
tions in tissue sampling. Specifically, the concentration
of creatine in glial cells is four times that of neurons in
the human brain.6 In addition, creatine concentration in
white matter is 80% of the creatine concentration in gray
matter.7 This can produce significant sampling errors,
especially in measurements of the N-acetylaspartate/
creatine ratio, as N-acetylaspartate in white matter has
been shown to be 113% the concentration of gray mat-
ter, producing variations in the N-acetylaspartate/crea-
tine of up to 40% in the same hemisphere. With consid-
eration of the “large voxel sampling” used for single
point spectroscopic evaluations in this study, the poten-
tial for error increases.
These factors have been taken into account in more
recent works through the use of tissue segmentation and
spectroscopic imaging. In the near future, significant re-
finements in these techniques should be expected. Works
currently underway utilizing higher intensity magnetic
fields and 31P MRS, and 1H MRS, are expanding the
present capabilities to include whole brain assessment and
detailed calculation of normal values for metabolite levels in
all brain regions.
Of additional concern, the authors report that internal
carotid artery volume flow measured with duplex ultra-
sonography was decreased before surgery and increased
after surgery. There was no attempt to correlate the in-
crease in carotid volume flow with an increase in cerebral
circulation. Doerfler et al8 used magnetic resonance imag-
ing to assess regional cerebral blood flow. The authors of
this manuscript, in a previous publication,9 used both du-
plex volume flow measurements and single photon emis-
sion computed tomography to assess cerebral blood flow.
In that study, internal carotid artery volume flow increased
significantly in all patients after carotid endarterectomy, but
actual improvement in cerebral perfusion only occurred in
13 patients (72.2%). This would suggest, on the basis of the
authors’ previous data, that internal carotid artery volume
flow does not necessarily correlate with an increase in
cerebral blood flow.
Further supporting the need for cerebral blood flow
measurement, 10 of the 18 patients studied had significant
contralateral disease. The data are compared for these two
subgroups in Table III of the article, and there appear to be
no significant differences. Does this suggest that measured
metabolic responses are not totally related to the degree of
ischemia (as one would expect ischemia to be worse in the
presence of contralateral disease), or does this suggest that
the measured metabolites vary with ischemia only to a
limited degree, after which there is a plateau in response?
The authors’ work represents a significant contribu-
tion in the effort to understand the effects of operative
therapy on the brain at the cellular level. 1H MRS, 31P
MRS, and functional magnetic resonance imaging are
now available in many medical centers and are used
clinically to aid in the diagnosis of neuronal disease. As
clinical experience grows and the technology advances,
the potential exists for more accurate staging of stroke
age, identification and characterization of the ischemic
penumbra, detailing of the biochemical response to ce-
rebral ischemia or infarction, and understanding of the
effects of pharmacologic and operative therapies to the
metabolism of the diseased brain.
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